NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

Even the Feb '17 PR implies an event driven completion, though then at 233 OS.

That events continue to collect as the scrub goes down is the norm in event driven trials. That is why most trials end up with somewhat more events than planned.

I simply fail to see how anybody can look at this trial and not see it was event driven to 248 PFS, then changed to 233 OS, then unknown.

It is OK though. Even if RK is right then data on all patients will be complete by 2030 or so. And the phone bill for OS follow will be trivial. Not long :-